• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail
?
-

Resources for You

NovoSevenRT

STN: BL 103665
Proper Name: Coagulation Factor VIIa (Recombinant)
Tradename: NovoSevenRT
Manufacturer: Novo Nordisk Inc, License #1261

Indication:

  • Treatment of bleeding episodes in hemophilia A or B with inhibitors and in acquired hemophilia (1.1)
  • Prevention of bleeding in surgical interventions or invasive procedures in hemophilia A or B with inhibitors and in acquired hemophilia (1.2)
  • Treatment of bleeding episodes in congenital FVII deficiency (1.3)
  • Prevention of bleeding in surgical interventions or invasive procedures in congenital FVII deficiency (1.4)
-

Supporting Documents

-
-

Related Information

-
 

Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002